|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | C07D 487/04 | (2006.01) |
| A61K 31/5025 | (2006.01) | ||
| A61P 35/00 | (2006.01) | ||
| A61P 43/00 | (2006.01) |
| (11) | Number of the document | 3800189 |
| (13) | Kind of document | T |
| (96) | European patent application number | 20208218.6 |
| Date of filing the European patent application | 2017-05-18 | |
| (97) | Date of publication of the European application | 2021-04-07 |
| (45) | Date of publication and mention of the grant of the patent | 2023-06-28 |
| (46) | Date of publication of the claims translation | 2023-10-10 |
| (30) | Number | Date | Country code |
| 201662338359 P | 2016-05-18 | US |
| (72) |
REYNOLDS, Mark , US
EARY, Charles Todd , US
SPENCER, Stacey , US
JUENGST, Derrick , US
HACHE, Bruno , US
JIANG, Yutong , US
HAAS, Julia , US
ANDREWS, Steven W. , US
|
| (73) |
Loxo Oncology, Inc. ,
281 Tresser Boulevard 9th Floor, Stamford, Connecticut 06901,
US
Array Biopharma, Inc. , 3200 Walnut Street, Boulder, CO 80301, US |
| (74) |
Reda ŽABOLIENĖ,
METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius,
LT
|
| (54) | (S)-N-(5-((R)-2-(2,5-difluorfenil)pirolidin-1-il)pirazolo[1,5-a]pirimidin-3- il)-3-hidroksipirolidin-1-karboksamido gavimas |
| PREPARATION OF (S)-N-(5-((R)-2-(2,5-DIFLUOROPHENYL)PYRROLIDIN-1-YL)PYRAZOLO[1,5-A]PYRIMIDIN-3-YL)-3-HYDROXYPYRROLIDINE-1-CARBOXAMIDE |
| Payment date | Validity (years) | Amount | |
| 2025-04-22 | 9 | 208.00 EUR |
| 2026-05-18 |